Webb24 juni 2024 · Miracor Medical secures CE Mark approval for PiCSO System. (Credit: Reaper DZ from Pixabay.) Miracor Medical SA (Miracor Medical) has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console, which is indicated for the treatment of anterior STEMI patients. WebbSponsors: Lead Sponsor: Miracor Medical SA Source: Miracor Medical SA Brief Summary: The objective of this study is to assess efficacy and safety of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) therapy started post flow restoration but prior to stenting during percutaneous coronary intervention (PCI) compared to standard …
Miracor Medical’s PiCSO System receives CE mark
Webb23 juni 2024 · Miracor Medical has developed the PiCSO Impulse System, the first and only coronary sinus intervention designed to reduce infarct size, improve cardiac function by … Webb23 aug. 2024 · PiCSO® Impulse Catheter (Photo: Business Wire) PiCSO-AMI-II will be the second major randomized trial to evaluate the role of PiCSO in improving coronary microvascular function and reducing... gabz vagos
Pressure-controlled Intermittent Coronary Sinus Occlusion …
Webb22 juli 2014 · The new PICSO (Pressure-Controlled Intermittent Coronary Sinus Occlusion) Impulse System, consisting of the Impulse Console and Impulse Balloon Catheters, is … Webb20 apr. 2012 · Study end-points 3.1 Primary endpoints 1. Duration from successful femoral vein cannulation until successful placement of PICSO Impulse catheter into the Coronary Sinus. 2. Relative increase in collateral flow pressure index (CFpI) during LAD occlusion with and without PICSO. 3.2 Secondary endpoints 1. Webb23 aug. 2024 · Miracor Medical has developed the PiCSO Impulse System, the first and only coronary sinus intervention designed to reduce infarct size, improve cardiac … gacek mon bazou